Where does Rottapharm SpA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rottapharm SpA ranks #42,731 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rottapharm SpA hold?

Rottapharm SpA holds 6 US utility patents granted between 2015 and 2024, spanning 7 technology areas.

What is Rottapharm SpA's Innovation Score?

Rottapharm SpA has an Innovation Score of 34.9 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Rottapharm SpA's patent grant rate increasing or decreasing?

Rottapharm SpA's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Rottapharm SpA's patents?

Rottapharm SpA's patents average 9.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rottapharm SpA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rottapharm SpA

Q: What technology areas does Rottapharm SpA focus on?

Rottapharm SpA's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 6 patents. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rottapharm ranks #42,731 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.

#42,731
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.9/100): 9.2
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R42731 · Foreign Corporation #42,731 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #42,731/49,997
PHOTO-FINISH Ronan Tools
CPC-NARROW A61P · 7 areas
INNOV-THIN 34.9/100
CLAIMS-PAR 9.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ronan Tools Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Mmodal IP · near

35
Rolex Watch U · near

35
Rottapharm SpA · this assignee

35
Shenzhen Sodi… · near

35
Vungle · near

35
3D Lighting… · lowest

7

What this shows Rottapharm's Innovation Score is 34.9/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Rottapharm's grants concentrate

Rottapharm SpA is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2017. By volume, Rottapharm sits between Ronan Tools Inc. and Rupp Marine, inc..

Rottapharm's three-year grant acceleration

Rottapharm SpA shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ronan Tools

6
Roof Asset Manage…

6
Roost

6
Ross Operating Va…

6
Rubicon Products

6
Rubreco

6
Rules Based Medic…

6
Rupp Marine

6
Rottapharm Spa ◀

6

What this shows Rottapharm holds 6 patents at rank #42,716, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rottapharm

By rank, the assignees closest to #42,716 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Rottapharm's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rottapharm, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Shenzhen Sodi Innovation Technologies Co., Ltd 35 Vungle, Inc. 35 Mmodal IP LLC 35 Rolex Watch U.S.A., Inc. 35

Rottapharm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rottapharm SpA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	33.3%
2017	1	16.7%
2021	1	16.7%
2022	1	16.7%
2024	1	16.7%

Which technologies does Rottapharm SpA patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 4

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

C07D - Heterocyclic Compounds 1

C08B - POLYSACCHARIDES; Derivatives Thereof 1

C08L - Compositions OF Macromolecular Compounds 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#42,731

of 49,997 tracked assignees

Innovation Score

34.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Rottapharm SpA's patent record in context - here's where to go next.

Rottapharm SpA's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #42,731 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rottapharm SpA against Ronan Tools Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.